State Street
BOLD icon

State Street’s Boundless Bio BOLD Stock Holding History

State Street’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$253K Buy
100,662
+84,700
+531% +$228K ﹤0.01% 3845
2026
Q2 		$39.9K Hold
15,962
– – ﹤0.01% 4166
2026
Q1 		$17.6K Hold
15,962
– – ﹤0.01% 4221
2025
Q4 		$19.2K Hold
15,962
– – ﹤0.01% 4245
2025
Q3 		$19.6K Hold
15,962
– – ﹤0.01% 4247
2025
Q2 		$16.1K Sell
15,962
-32,224
-67% -$42.8K ﹤0.01% 4215
2025
Q1 		$72.8K Buy
48,186
+4,109
+9% +$8.52K ﹤0.01% 4031
2024
Q4 		$128K Buy
44,077
+18,712
+74% +$54.5K ﹤0.01% 3943
2024
Q3 		$88K Buy
25,365
+4,100
+19% +$14.9K ﹤0.01% 4001
2024
Q2 		$82.3K Buy
+21,265
New +$203K ﹤0.01% 4055

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

State Street's BOLD Position: Q3 2026 in Review

State Street increased its Boundless Bio (BOLD) stake by 531% in Q3 2026, buying an estimated $228K and bringing the position to 100,662 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #3845.

State Street first reported a position in BOLD in Q2 2024 and has held it in 10 quarters since. 8 funds tracked by Wall St. Rank hold BOLD as of Q3 2026.

  • State Street held 100,662 shares of Boundless Bio worth $253K as of Q3 2026.
  • State Street bought 84,700 Boundless Bio shares in Q3 2026, an estimated $228K.
  • Boundless Bio made up ﹤0.01% of State Street's portfolio in Q3 2026, its #3845 holding.
  • State Street first reported a position in Boundless Bio in Q2 2024 and has held it in 10 quarters since.
  • 8 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.